TP53 and bladder transitional cell carcinoma: Furthermore, in BLCA, lung squamous cell carcinoma (LUSC), and SKCM, the p53 wild-type group with high NEAT1 expression had a good prognosis compared with the group with low NEAT1 expression, while the p53-mutated groups did not exhibit a significant prognosis difference based on NEAT1 expression (Supplementary Figure 4).